Affymetrix, InterMune slide in early action
April 28, 2011 at 11:24 AM EDT
Meanwhile, shares of Bristol-Myers Squibb edge up after the pharmaceutical company reported a better-than-expected first-quarter profit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.